Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Инструмент за оценка на тежестта на заекването – Четвърто издание× | Индекс на гласова инвалидност× | |
|---|---|---|
| Област | Логопедия | Логопедия |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | 2009 | 1997 |
| Създател≠ | Riley, G. D. | Jacobson, B. H., et al. |
| Тип≠ | Clinician-rated | Self-report |
| Основополагащ източник≠ | Riley, G. D. (2009). Stuttering Severity Instrument for Children and Adults–Fourth Edition (SSI-4). Austin, TX: Pro-Ed Publications. ISBN: 978-1-59820-072-7 | Jacobson, B. H., Johnson, A., Grywalski, C., Silbergleit, A., Jacobson, G., Benninger, M. S., & Newman, C. W. (1997). The Voice Handicap Index (VHI): Development and Validation. American Journal of Speech-Language Pathology, 6(3), 66–70. DOI ↗ |
| Други названия≠ | SSI-4, SSI, Stuttering Severity Index | VHI, VHI-30 |
| Свързани≠ | 3 | 2 |
| Резюме≠ | The Stuttering Severity Instrument–Fourth Edition (SSI-4) is the standard clinician-administered measure of stuttering severity in children (ages 2–13) and adults (ages 14–75). Developed by Riley (2009), SSI-4 quantifies stuttering through three behavioral components: frequency (percentage of syllables stuttered), duration (average length of stuttering moments), and physical concomitants (observable tension and associated movements). SSI-4 Severity Scores enable reliable tracking of treatment response, prognosis estimation, and comparison across populations, making it essential for evidence-based stuttering assessment and research. | The Voice Handicap Index (VHI) is a 30-item self-report questionnaire that measures the impact of voice disorders on quality of life and functional communication. Developed by Jacobson and colleagues in 1997, it quantifies the psychosocial, physical, and emotional burden of dysphonia across functional, physical, and emotional domains. Widely used in otolaryngology and speech-language pathology to assess treatment outcomes and monitor disease progression. |
| ScholarGateНабор от данни ↗ |
|
|